HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis.

AbstractUNLABELLED:
Most studies on the prevalence of asialoglycoprotein antibodies have involved adults. In this study the prevalence of antibodies to the human asialoglycoprotein receptor (ASGP-R) was determined in 63 children with auto-immune hepatitis. It was shown that 75% of those with auto-immune hepatitis type 1 and 40% of those with auto-immune hepatitis type 2 were positive and the presence of anti-ASGP-R auto-antibodies, at a mean titre of 1:1,600 and 1:1,000 respectively. No statistical significance was found between anti-ASGP-R positive and negative patients with respect to the median age at onset, proportion of females and ALT levels. However, the titre of anti-ASGP-R antibodies correlated significantly with hypergammaglobulinaemia.
CONCLUSION:
Anti-asialoglycoprotein receptor antibodies are frequently present in the sera of children with auto-immune hepatitis, particularly type 1, The presence of these antibodies is an indirect marker of inflammatory activity.
AuthorsO Hajoui, D Debray, S Martin, F Alvarez
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 159 Issue 5 Pg. 310-3 (May 2000) ISSN: 0340-6199 [Print] Germany
PMID10834513 (Publication Type: Journal Article)
Chemical References
  • Asialoglycoprotein Receptor
  • Asialoglycoproteins
  • Autoantibodies
  • Receptors, Cell Surface
  • gamma-Globulins
Topics
  • Adolescent
  • Asialoglycoprotein Receptor
  • Asialoglycoproteins (immunology)
  • Autoantibodies (blood)
  • Autoimmune Diseases (blood, immunology)
  • Child
  • Child, Preschool
  • Female
  • Hepatitis (blood, immunology)
  • Humans
  • Male
  • Receptors, Cell Surface (immunology)
  • gamma-Globulins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: